Childbearing after liver transplantation by Scantlebury, V et al.
.l; 
... 
. ;;-
, 
,.. 
i. 
t 
Vol. 49, 317-321, No. 2, r.brual') )9'30 
PrinUd L1l V S.A 
CHILDBEARING AFTER LIVER TRANSPLANTATION1,2 
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Seventeen female patients who underwent orthotopic 
Uver transplantation between June 1973 and June 1987 
beCame pregnant 5 months to 11 years after transplan-
tation. Immunosuppression was maintained with com-
binations of prednisone, cyclosporine, ~nd ~thioprine 
prior to and during pregnancy. One patient discontinued 
1.IIuDunosuppression after knowledge of pregnancy, tak-
log only azathioprine sporadically. Mean age at time of 
delivery was 26 years. Twelve patients had no altera-
tion in liver function studies; 7 patients demonstrated 
mild or moderate enzyme elevations prior to delivery, 
witb one case of rejection confirmed hy percutaneous 
liver biopsy. Major problems related to pregnancy were 
hypertension, anemia, and byperbilirubinemia. Twenty 
live births occurred (2 patients had 2 separate pregnan-
cies, one patient had a set of twins); 13 were by caesarian 
section, 7 by vaginal delivery. Eleven of the 13 caesar-
Ian births were premature by gestational age. All vagi-
nal births were term. Toxemia of pregnancy and early 
rupture of membranes were tbe principal indications for 
_ caesarean section. 
There were no congenital abnormalities or birth de-
fects and all the children are surviving well. Fifteen of 
18 children older than one year all have normal physical 
and mental development, with one child manifesting 
immature speech development. Four children are under 
one year, all with normal milestones thus far. Sixteen 
of tbe 17 mothers are alive from 2-18 years after trans-
plantation; the only death was from a lymphoma, almost 
.. years after transplantation and 21h years after deliv-
ery. This experience suggests that women undergoing 
liver transplantation can safely bear children despite an 
increased risk of premature caesarian birtbs. The effect 
or chronic immunosuppression of female pediatric pa-
tients on their reproductive potential later in adulthood 
remains to be fully evaluated but the results so far are 
favorable. 
Liver transplantation (OLTx) has been performed success-
fully in the United States since 1967, with over 2000 transplants 
carried out at the Vniversity of Colorado and the University of 
Pittsburgh combined. Since the introduction of cyclosporine in 
1980, improved long-term survival rates have been achieved. 
Subsequently, more patients are able to return to a relatively 
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normal style of liviD«- This near-normalcy has been aCCOm-
panied by increasinc desire to bave children despite concern 
associated with the long·term use of immunosuppressive med-
icationa. 
Since the first 5U(Xessful pregnancy in a liver transplant 
recipient took place in 1976 (1, 2), a total of 20 infants have 
been born to 17 liver transplant recipients wbo underwent 
surgery in the combined programs of the University of Colorado 
and the University of Pittsburgh. To the best of our knowledge, 
this is the first large series of patients who, after liver trans· 
plantation. have experienced childbirth. 
We now report the results oCthese 20 births, which occurred 
between 1977 and 1988. The outcome and complications during 
pregnancy were assessed along with the alterations in hepatic 
function that occurred pre· and postdelivery. 
MATERIALS AND METHODS 
Patient fXJPUlation. Three patients underwent liver transplantation 
at the Cnh.-ersity of Colorado between 1973 and 1979, with the remain-
ing 14 receiving transpla:Jti at the University of Pittsburgh during the 
period from 1983 to 1987. Table 1 summarizes the clinical history of 
these patients. Mean agt of all patients was 25 yean at time of 
pregnAllCY. Average time from transplantation to diagnosis of preg-
nancy ",·u 26 months (range of 5 months to 11 years). The youngest 
patient., transplanted for biliary atresia at 4.5 yean of age, subsequently 
became pregnant 11 years later. All other patients were adults at the 
time of lh·er tl1lnsplantstion. 
All but one patient underwent I single liver transplantstion. with 
one retransplantstion O«'.llTing due to primary nonfunction of the 
initial graIL Immunosuppression consisted of azathioprine, prednisone 
and antilymphocyte globulin prior to 1980 and cyclosporine-prednisone 
after 1980. Az..athioprine was added to the cyc1osporine'prednisone 
regimen in only one pati~nt prior Ul and during pregnancy. One patient 
discontinuM immunosupp~ion at the time of diagnosis of pregnancy. 
which occuTTt'd nearly one year after ber liver transplant. She now 
remains off all immunosupjlression with normal liver function studies. 
In the cydosporine-steroKi era, one patient received ALG and four 
received OKT3 for treatmf::t of severe rejection in the initial 6 Wetka 
following tran."'plantation. Sone required retransplantation for rejec-
tion. Follo .... -ing discharge, all patients continued to be followed by 
physicians in Pittsburgh but were primarily managed by their initial 
referring physician and obs:.ttrician. 
Gynecological history. bf~pt (or one pediatric patient, all patients 
were within the childbearing yean at the time of liver transplantation. 
Five patients had had chig~n prior to their OLTx. One developed 
Budd·Chiari syodrome &ealDdary Ul the use of medroxyprogestone 
acetate for infe!"tility (1). This led Ul progressive liver failure requiring 
liver transplantation 2 years later. Following her transplant, ovulation 
was again ir,c'xed by clomi;~ene citrate, resulting in a pregnancy 18 
months after her OLTx. 1\t.-o additional patients had diffICulty main. 
taining pregnancies pre-OLTx. One clomiphene-induced pregnancy 
aborted in the first trimester; the other patient 8uffered 2 spontaneous 
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TABLE 1. Clinical information about patientl 
IDt.tr"a.! from 
~Kt ai~ OLTsto Parity m~1K1fCDFD m~ Pre·OLfi Patitnt fD~ancy alOLTllO No. No. (y..-") (OX'ntha) 
BiliaI)' atreC~ 138 Premenarcbe 16 1 1 18 PoGo 
2 2 26 
Budd-Chiari syndrome 
48 28 2 3 11 mIdoA~ 
4 23 Wilson's Disea.se P.G,Aba 3 Chronic: active bepatitia 11 6 27 PIG. 4 36 Sclerosing cbolangitia 
6 6 30 12 PoGo 
6 7 33 Chronic active hepatitia PoGo 22 
7 8 29 Cryptogenic cirrbosia 32 31 7 9 Chronic active hepatitia 22 p.G. 8 10 23 pKdoA~ Chronic active bepatitia 7 9 11 25 P.o. Chronic active hepatitia 12 10 12 19 P,G. Secondary biliary cirrbosia 6 11 13 27 PoGo Chronic active hepatitia 8 12 14 25 P.o. Primary bi\iazy cirrb08i1 18 13 15 31 p.G. 22-Acute hepatic failure 14 16 23 
17 22 14 Sclerosing cholangitia 5 p.G. 15 18 22 PoGo Alpba-l.antitrypsin deficiency 6 16 19 20 mIdoA~ 17 20 33 Chronic active bepatitia 12 
• OL Tx: Ortbotopic liver transplantation. 
• Patient delivered twins_ 
abortions and one ectopic pregnancy before successfully having a full· 
term pregnancy_ Both of these patients conceived within a year after 
OLTL . 2 
There were three reported therapeutic abortions occurring In 
patients after OL Tx. Two were performed in a rec:ipient after she had 
had a difficult premature delivery; tbe IK'ODd patIent later completed 
a second pregnancy. One spontaneous abc.rtion occurred after OL ~xK 
This patient became a mother twice within the next 3 years followLDg 
herOLTx. 
Pregrumcy management. All recipients ... ere classified as high·risk 
pregnancy patients and managed by both tbeir obstetrician and the 
Pittsburgh group. Three patients required hospitalization and obser· 
vation for at least one week prior to delivery. Only one patient was 
required to return to Pittsburgh for bospit.aliud management in the 
perinatal period. 
RESULTS 
From 1977 to 1988, 17 recipients cf orthotopic liver trans· 
plantation gave birth to 20 infants, 1-12 years after their liver 
transplantation (mean 2.6 years). Mean age at the time of 
delivery was 26 years. The results of the pregnancies are listed 
in Table 2. There were 7 normal spontaneous vaginar deliveries 
(NSVD)O and 12 caesarean sections (l'CS) (one patient had a 
set of twins). All infants born by NSVD were full term (37%). 
Mean birth weight in this group was 2940 g. Only one patient 
who delivered by NSVD had toxemia p:e-cipitating delivery; all 
others were without complications. 
Ten of the remaining 13 neonates delivered by 1 ·CS were 
premature by gestational age (83%). ~iean birth weight was 
1980 g, with a mean gestational age of 34 weeks. Three patients 
required l'CS due to severe toxemia of pregnancy that occurred 
at 28,32, and 35 weeks' gestation. The infant born at 28 weeks' 
gestation required ventilatory assistance for 7 days due to 
• Abbreviations CS, caesarian section; ~psaI nonnal spontaneous 
vaginal deli"ery; PROM, premature rupture of membranes; PTC, per· 
cutaneous transhepatic chalangiograpby. 
immaturity of the lungs. Premature rupture of membranes 
(PROM) precipitated early I'CS in two patients at 28 and 35 
weeks' gestation. Fetal distress and prolonged labor due to 
cephalopelvic disproportion, breech presentation, and trans· 
verse lie of the fetus each caus.ed I·CS. One set of twins, born 
at 34 weeks, sustained intrauterine growth retardation that 
necessitat~ I·CS. Only one patient experienced severe discom-
fort in the area of the liver along with increasing liver enzymes 
abnormalities. This resulted in l'CS performed at 32 weeks. 
Liver function studies. Of 19 pregnancies, 12 were character· 
ized by relatively stable liver function studies as reflected in 
the transaminases and bilirubin (Table 3). Some patients demo 
onstrated mild·to·moderate elevations in alkaline phosphatase 
but this was attributed to normal pregnancy changes. Chronic 
rejection was the diagnosis made in one patient whose trans· 
aminases were elevated at the beginning of pregnancy. This 
patient continued to sustain ongoing injury and progressive 
hyperbilirubinemia throughout her pregnancy. There were four 
cases of mildly elevated liver function tests, with the bilirubin 
more significantly elevated than the rise in transaminase. All 
were followed closely and required no treatment up until time 
of delivery. 
Moderate elevations in liver functions were seen in three 
patients. One underwent a li .... er biopsy demonstrating acute 
rejection along with areas of hepatitis. This patient had treat· 
ment deferred until aft~r deli .... ery one week later. Partial reso· 
lution of the elevated liver enzymes occurred before treatment 
was undertaken. Another patient.. with a diagnosis of recurrent 
hepatitis B prior to pregnancy, underwent a liver biopsy 2 
months before delivery. This was reported as mild hepatitis. 
!\o rejection was seen. The third patient, who had a biopsy at 
the beginning of pregnancy, was reported to have chronic 
rejection. Further workup for progressive enzyme elevation was 
deferred until the postpartum period. 
Significant changes in hepatic function were brought about 
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TA.BLE 2. Results of childbirth in 17 female liver transplant recipients 
p~cnCaCDFD 
~KyAtional Type 0( APGAR So Weicht ComplicauoDi 
No. Ate deli~ry aeoN (e) ( .. ·ee .... ) 
1 1 39 NSVD· 9 F 3660 None 
2 2 40 NSVD 9 M 2400 None 
3 41 NSVD 9 F 2S5O None 
3 
" 
40 NSVD 9 F 3160 None 
4 6 28 1· es 8 M 1220 Toxemia, respiratory insufficiency 
6 6 35 res 9 F 2400 Premature ROM 
6 7 38 1· es 9 M 3090 Transverse lie 
7 8 34 res 9 M 1690 Fetal distrea, anemia, hypertension in mother 
., 9 39 1· es 9 M 2020 None 
8 10 38 NSVD 
., , 3060 Anemia 
• 11 38 
NSVD 9 , 2550 None 
10 12 32 1· es 9 M 2100 Discomfort and enzyme abnormality of liver 
11 13 38 NSVD M 3210 Toxemia and anemia 
12 14 36 1· es 3 M 1690 Toxemia, anemia, intrauterine powth retardation 
13 16 35 1· es 8 M 2870 Toxemia. anemia 
14 16 34' 1· es 9 M 1020 Anemia, HTN, intrauterine crowth retardation 
14 17 34' (TwiDa) 8 M 1330 Anemia, HTN, intrauterine powth retardation 
16 18 28 1· es 9 F 1460 Premature ROM 
16 19 35 1· es 9 M 2500 Prolonged Iahor 
17 20 35 1· es F 2330 Breecb presentatioD 
• CS, caesarian section NSVD: normal spontaneous vaginal delivery; ROM: rupture of membranes; HTN: hypertension. 
tTwina. 
TABLE 3. Alterations in liver function testa seen during 19 
pregnancies after OL TJ 
A1terationa in t.Hta 
Anterpartum period 
Stable LFT." 
Mild elevations in LIT. 
Moderate elevations in LFT. 
Postpartum period 
Stable LFT. 
Moderate elevation in LFT. 
Spontaneously resolved 
Treated with steroid bolus 
PTe and liver biopsy done 
No. P.tienta 
12 
4 
3 
9 
10 
3 
" 3 
• LIT: liver function test; PTC: percutaneous transhepatic cholan-
pogram. 
by delivery of the newborn. Nine cases showed no significant 
change in liver enzymes within eight weeks postpartum. Simi-
larly, 10 cases of persistent abnormalities in hepatic function 
were recorded (Table 3). Three resolved spontaneously without 
any intervention. One with known hepatitis B had another 
biopsy at 2 months postpartum that revealed ongoing hepatitis. 
~finimal-to-mild rejection also noted was not treated. An ad-
ditional four patients were given a steroid bolus for treatment 
of enzyme abnormalities seen from 2 to 8 weeks postpartum. 
One patient showed an immediate improvement in hepatic 
function. Three remained unchanged initially, but spontaneous 
resolution occurred within 4 weeks. None of these patients had 
a liver biopsy performed for definite diagnosis. Percutaneous 
transhepatic cholangiography (PTC) was performed on three 
additional patients for enzyme elevations postpartum. Two had 
simultaneous biopsies that revealed no rejection: one was nor-
mal, the other consistent with cell swelling and vacuolization. 
Both PTCs demonstrated normal biliary duct architecture. The 
~---~~-~--- --- ~ ---~~-
third patient, presumed to have chronic rejection on a previous 
biopsy, demonstrated multiple duct strictures and abscesses on 
PTC. Several drainage procedures were required, followed by 
retransplantation 2 months later. Thrombosis of the donor 
bepatic artery was revealed at surgery, a rmding not detected 
on earlier sonographic evaluatioDl. 
Immunosuppression. Except (or one patient who voluntarily ~ 
discontinued her medication, all other patients remained on 
standard therapy, as before pregnancy. Two received azathi-
oprine and prednisone; thirteen took CsA and prednisone. None 
had significant changes in dosages. One patient received triple 
therapy during the course of her pregnancy. Five patients 
required a decrease in dosages of CsA primarily in the last 
trimester. Three were decreased because of elevated CsA blood 
levels; one. for deterioration in renal function. The fifth pa-
tient's dosage was decreased because of persistent hepatitis on 
liver biopsy. The dose of prednisone remained the same 
throughout the pregnancy course in all patienta. 
Complications. Six cases were complicated by hypertension 
requiring treatment. Four of these had associated toxemia of 
pregnancy requiring 1·CS for early delivery. Anemia was also 
a significant problem in six others, two of whom required blood 
transfusions in midpregnancy. Hyperbilirubinemia was also 
seen in six cases, as discussed earlier, with this manifestation 
also associated with elevated transaminases. Single cases each 
of urinary tract infection witb stones, adrenal insufficiency, 
and endometritis were reported 88 maternal complications. 
Among the neonates, intrauterine growth retardation was seen 
in 4 infants, including one set of twins; birth weight averaged 
1400 g. Although small for gest.ational age, none required ven-
tilatory assistance. Respiratory insufficiency was noted in one 
infant born at 28 weeks gestation, as a result of toxemia in tbe 
mother. In addition to hyaline membrane disease, this infant 
suffered both apneic and bradycardiac episodes, as well 88 
hyperbilirubinemia due to neonatal jaundice. Abnormality of I 
I 
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eveloproent was noud in this child at age 2.5 years. 
;tional infant suff('re-d also from neonatal jaundice but 
ved without s.e-quelae. Another infant, born to a mother 
Idone (and HbsAg+), sustained methadone-withdrawal 
18. 
were no reported cases of congenital abnormalities or 
-'Cts_ With the exception of immature speech develop-
>De child, all otbers continue to grow and demonstrate 
evelopmenL Ages presently range from 9 months to 
Fifteen children are still under 3 years of age but all 
Jrmal developmental pattern. No cases of adrenocor-
fficiency or lymphopenia were reported in this series 
'. 
ild born to a mother with Wilson's disease has been 
be a heterozygote for the gene, with normal serum 
d urinary excretion of copper_ This child is presently 
. age with normal liver function studies. One infant, 
mother with hepatitis B, showed no liver dysfunction 
)pathy. She was immediately vaccinated and is now 
at 10 months. 
maUrnal survivaL Sixteen oBhe 17 mothers are alive 
) 18 years after transplantation. The seventeenth 
vas a 25-year-old woman (patient 9) who delivered a 
by 161ft months after transplantation, and died of a 
phoma 21fl years later. 
DISCUSSION 
lDsplantation has been performed for more than two 
pproximately 11 % of those transplanted have been 
ients in their childbearing years who have expressed 
desire to resume a normal family life. Within the 
-s, there has been a larger population of pediatric 
'ming to liver transplantation, representing nearly 
patients transplanted, and having a greaur than 
e of survival into and beyond the reproductive years. 
luctive potential of these patients is of significant 
those involved. Previously reported cases of preg-
wing liver transplantation have been isolated case 
3)_ Much more has been writun about pregnancy 
'nal transplantation. including a comprehensive re-
oregnancies from the University of Minnesota (4) 
gnancies caused by both male and female renal 
'rom the University of Colorado (5). Many more 
ns to the mother and the newborn were reported. 
1e death and the development of carcinoma in two 
?nn et aI. (5) reported a 49% rau of prematurity 
omplication rau among newborns of female kidney 
ncluding respirat()ry distress. congenital abnormal-
:>cortical insufficiency. infection. liver dysfunction. 
rt of 20 live births from 17 recipients of liver 
:ion is the largest series so far. From our experience 
'en no increased risk due to the physical presence 
>. Although 11/18 (60%) pregnancies were un-
re were only three additional pregnancies that were 
In 2 of our mothers for nonmedical reasons. but 
s subsequently delivered live babies. 
. the major concern to the mother was the potential 
function. Although the incidence of elevated he-
es was 35% during the course of the pregnancy, 
11y one documenud case of acute rejection with 
hepatitis occurring in the third trimester. Res<>lution was seen 
e .... en before treatment was initiated and upon delivery of the 
fetus. Howe .... er. the abnormalities in hepatic function associ-
atro with the delivery process were in most cases not consisunt 
with reje<:tion. Those that were treated blindly had only a 25911 
response to steroids. Greaur than 80% of those not treated 
resolved spontaneously, with 2 undergoing biopsies that re-
vealed no reje<:tion. Therefore the progressive elevation in liver 
function seen after delivery did not correlate with rejection. 
One of the most significant findings was the 63911 incidence 
of caesarian sections. Among this group was an 83% prematur-
ity rate with a mean gestational age of 34 weeks. The main 
cases of 1 'CS included toxemia and premature rupture of 
membranes. Despite the larger number of premature babies 
(55% overall), only one infant had respiratory insufficiency due 
to hyaline membrane disease, which required intubation for 
seven days. The risk of prednisone therapy to the fetus may be 
associat.ed with respiratory distress. lymphopenia, and adre-
nocortical insufficiency. These effects were not manifested in 
the offspring of our patients, and there were no infectioua 
complications in the infants as a result of exposure to chronic 
immunosuppression. 
One patient. concerned about the long·term effects of im-
munosuppression, chose to discontinue her therapy during her 
pregnancy. Fortunately this patient suffered no sequelae and is 
still maintaining normal liver function now 7 years'later. The 
effect of azathioprine on offspring is of great concern since it 
has be€n shown to produce congenital abnormalities and chro-
mosomal aberrations in experimental animals (6, 7). However, 
three of our patients were immunosuppressed with azathioprine 
during their pregnancies, with one patient having 2 separate 
pregnancies. All children are without obvious effects of the 
immunosuppression. 
There was a single case in which ALG was used and 5 cases 
with OKT3 in patients prior to pregnancy. The long·urm 
effects of these medications is unknown. CycIosporine. known 
to pass transplacentally. has not shown any adverse effects in 
neonates born to mothers chronically immunosuppressed with 
this drug. Tests conducud by Sandoz. Inc .• have not shown 
CsA to be mut8genic and cycJosporine has not been shown to 
produce chromosomal abnormalities in animals. There were 
also no reported septic complications in the neonaus as a result 
of this chronic exposure. and no obvious long·term complica-
tions ..... ere noted. T ..... o patients who delivered their babies in 
Pittsburgh underwent measurements of CsA metaboJius in 
cord. placenta. and maurnal blood (8). It appeared that a very 
high concentration of metabolites occurred in the placenta and 
umbilical cord. concentrations nearly 10-20 times that seen in 
maurnaJ blood. Burrows et a1. (9) reported cord blood levels of 
CsA that were 34% and 57% of maurnal CsA levels found at 
delivery in twins born to a mother on CsA and prednisone. 
These babies were delivered at 35 weeks' gestation as a result 
of preeclampsia. 
In summary. 17 patients following liver transplantation have 
given birth successfully to 20 healthy children. despiu chronic 
immunosuppression. Three children were born to mothers on 
azathioprine and steroids. all with full-urm and vaginal deliv-
eries. Sixteen children were exposed to cyclosporine and ste-
roids. with known passage of this immunosuppressant across 
the placenta. Coincidentally, a larger percentage of these in-
fants was premature (68%) and small for gestational size. 
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)espite the increased risk of prematurity and increased number 
,f caesarian births, our experience suggests that liver trans· 
,Iantation i. not a contraindication to bearinc children. The 
ffect of chronic immunosuppression on pediatric recipients of 
:\'er transplantation and the subsequent danger to alterations 
n their reproductive capacity later in adulthood has yet to be 
valuated, but the prospects remain favorable. 
Addendum. Information regarding an 18th patient and sub· 
eQuent birth of 2 children was obtained after completion of 
his article. 'This patient underwent bel' OLT ill Denver, Colo-
ado at the age of 23 for chronic active hepatitis, and was 
'elivered of her first baby 7 years later. The ehild was born 
,rematurely around 30 weeks gestation, and weighed 1100 g. 
mmediately following delivery, the mother required emergency 
Iparotomy for sman bowel obstruction secondary to internal 
erniation of jejunum through the mesentery of her Roux·en· 
. loop. The baby required two operative procedures: the first 
Ir correction of a cardiac abnormality and the second to 
revent detachment of her retina (specific details not obtained). 
lother and child subsequently did wen, and the baby was 
:scharged at 3 months, No hepatic enzyme abnormalities were 
,ported during this pregnancy. 
Three and a half years later, the patient was delivered of a 
cond child, noted to be small for gestational age. Workup for 
ilure·to·thrive revealed the baby, and subsequently the 
other, to be positive (or the buman immunodeficiency virus. 
he child, now 6 months of age, is doing poorly and the mother 
11·1337190/4902·0321 $02.00/0 
ASSPUNTAnON 
pyrieht e 1990 by Williams &. Wilkins 
unfortunately died of complications secondary to her HIV 
infection, 11th years after liver transplantation. 
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IMPROVED RESULTS USING OKT3 AS INDUCTION 
IMMUNOSUPPRESSION IN RENAL ALLOGRAFT RECIPIENTS 
WITH DELA YED GRAFT FUNCTION 1,2 
ALAN I. Bb~y·bklpqyIPK4 DAVID ClebkI~ MARK D. STEGALL: A~a MARK A. HAROy4 
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DF~fayed graft function remains a major problem in 
laveric renal allograft transplantation. We have used 
lifferent immunosuppressive induction regimens in 
tients with delayed graft function. The first regimen, 
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used in 40 patients from January 1985 to December 
1986, consisted of CsA (8 mg/kgJday, orally within 48 
hr of cadaveric renal transplantation regardless of graft 
function), azathioprine (1.5-2.5 mg/kg/day), and ste-
roids (methylprednisolone 375 mg on day 0, then pred-
nisone tapered to 30 mg/day by day 10 with slow taper-
ing to 7.5-10 mg/day over the first 6 months after 
transplantation), A second regimen, used from January 
1987 to March 1989, employed the same doses of azathi-
oprine and steroids; however, OKT3 (5 mg i.v./day for 
7-21 days) was Udminist~red in the 34 patients who had 
delayed graft function. CsA was withheld until ATN 
resolved. 
The use of OKT3 as induction immunosuppression in 
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